Secondary Navigation Menu

WSF OpenID Connect Login

Brand Navigation Banner


Nebido® is a prescription medicine used in adult men for testosterone replacement to treat various health problems caused by low testosterone levels (male hypogonadism).
Nebido® contains testosterone undecanoate, a male hormone, as the active ingredient. Following the intramuscular injection of Nebido®, as an oily solution, the compound is gradually released from the depot over a period of time.
Serum testosterone levels should be measured before the start of treatment. The interval between the 1st and 2nd injections may be reduced to a minimum of 6 weeks. With this loading dose, steady-state levels will be reached quickly.
Thereafter one ampoule / vial of Nebido® (corresponding to 1000 mg testosterone undecanoate) is injected every 10 to 14 weeks.
Reference: Nebido® Professional Information South Africa April 2005